cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Vaxxinity Inc
4 own
6 watching
Current Price
$4
$0.16
(4.17%)
logo-vaxx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
504.22M
52-Week High
52-Week High
8.35
52-Week Low
52-Week Low
1.24
Average Volume
Average Volume
0.62M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization504.22M
icon52-Week High8.35
icon52-Week Low1.24
iconAverage Volume0.62M
iconDividend Yield--
iconP/E Ratio--
What does the Vaxxinity Inc do?
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer s disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin gene-related peptide to fight migraines; anti-PCSK9 that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; and UB-612 for neutralizing the SARS-CoV-2 virus, which is in phase 3 clinical trial. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas.
Read More
How much money does Vaxxinity Inc make?
News & Events about Vaxxinity Inc.
Ticker Report
5days ago
Vaxxinity, Inc. (NASDAQ:VAXX Get Rating) major shareholder Movers Lab Fund I. Lp Prime sold 405,217 shares of Vaxxinity stock in a transaction that occurred on Monday, January 23rd. The stock was sold at an average price of $3.35, for a total transaction of $1,357,476.95. Following the ...
Globe Newswire
27days ago
DALLAS, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today announced that Mei Mei Hu, Chief Executive Officer of Vaxxinity, will present an update on the Company and its pipeline at the 41st ...
Ticker Report
1month ago
Vaxxinity, Inc. (NASDAQ:VAXX Get Rating) major shareholder Movers Lab Fund I. Lp Prime sold 270,964 shares of the businesss stock in a transaction on Thursday, December 1st. The stock was sold at an average price of $2.97, for a total transaction of $804,763.08. Following the ...
Globe Newswire
2 months ago
Vaxxinitys next-generation COVID-19 booster candidate UB-612 achieves primary and key secondary immunogenicity endpoints in a pivotal head-to-head heterologous booster trial against three authorized vaccine platforms: mRNA (Pfizer-BioNTechs BNT162b2), adenovirus vector (AstraZenecas ChAdOx1-S), and ...
Globe Newswire
5 months ago
UB-612 Phase 3 COVID-19 Heterologous Boost Trial on Track for Topline Readout in Fourth Quarter of 2022 UB-312 Phase 1 Part B Trial for Parkinsons Completes Last Patient Last Dose, and Remains on Track to Complete an End-of-Treatment Analysis in the Second Half of 2022 Advanced UB-313 Anti-CGRP ...
Frequently Asked Questions
Frequently Asked Questions
What is Vaxxinity Inc share price today?
plus_minus_icon
Can Indians buy Vaxxinity Inc shares?
plus_minus_icon
How can I buy Vaxxinity Inc shares from India?
plus_minus_icon
Can Fractional shares of Vaxxinity Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Vaxxinity Inc stocks?
plus_minus_icon
What is today’s traded volume of Vaxxinity Inc?
plus_minus_icon
What is today’s market capitalisation of Vaxxinity Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Vaxxinity Inc?
plus_minus_icon
What percentage is Vaxxinity Inc down from its 52-Week High?
plus_minus_icon
What percentage is Vaxxinity Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4
$0.16
(4.17%)
logo-vaxx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00